Cost-Effectiveness of Fluticasone Propionate Administered Via Metered-Dose Inhaler Plus Babyhaler™ Spacer in the Treatment of Asthma in Preschool-Aged Children

To evaluate the cost-effectiveness of inhaled fluticasone propionate (FP) in children aged 12 to 47 months with asthma symptoms. A retrospective economic analysis conducted from the perspective of the Danish health-care system, based on clinical data from a 12-week study. Thirty-three outpatient cen...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Chest 2001-12, Vol.120 (6), p.1835-1842
Hauptverfasser:	Bisgaard, Hans, Price, Martin J., Maden, Claire, Olsen, Niels A.
Format:	Artikel
Sprache:	eng
Schlagworte:	Androstadienes - administration & dosage Androstadienes - adverse effects Androstadienes - economics Anti-Asthmatic Agents - administration & dosage Anti-Asthmatic Agents - adverse effects Anti-Asthmatic Agents - economics asthma Asthma - drug therapy Asthma - economics Biological and medical sciences Child, Preschool cost effectiveness Cost-Benefit Analysis Denmark Dose-Response Relationship, Drug Double-Blind Method Drug Administration Schedule Female Fluticasone fluticasone propionate Humans Infant Male Medical sciences National Health Programs - economics Nebulizers and Vaporizers - economics Pharmacology. Drug treatments preschool children Respiratory system Retrospective Studies Treatment Outcome
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!